Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey E Green

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Journal of Visualized Experiments : Jove|August 24, 2011
An in vitro system to study tumor dormancy and the switch to metastatic growthDalit Barkan, Jeffrey E Green
Nature Reviews. Cancer|March 2, 2005
The promise of genetically engineered mice for cancer prevention studiesJeffrey E Green, Tamaro Hudson
Cancer Immunology, Immunotherapy : CII|November 16, 2011
MicroRNA regulation in cancer-associated fibroblastsOlga Aprelikova, Jeffrey E Green
The Journal of Nutrition|July 4, 2003
The use of genetically altered mice for breast cancer prevention studiesClaudine Kavanaugh, Jeffrey E Green
Nucleic Acids Research|July 31, 2003
Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactionsStanislaw J Kaczmarczyk, Jeffrey E Green
Pharmacogenomics|February 19, 2014
Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agentsHark Kyun Kim, Jeffrey E Green
Breast Cancer Research : BCR|October 3, 2008
Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical modelsChristina N Bennett, Jeffrey E Green
Toxicologic Pathology|January 19, 2010
Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancerChristina N Bennett, Jeffrey E Green
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthDalit Barkan, Jeffrey E Green, Ann F Chambers
Anticancer Research|June 9, 2016
Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell LinesDong-Joon Min, Siping He, Jeffrey E Green
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Journal of Visualized Experiments : Jove|August 24, 2011
An in vitro system to study tumor dormancy and the switch to metastatic growthDalit Barkan, Jeffrey E Green
Nature Reviews. Cancer|March 2, 2005
The promise of genetically engineered mice for cancer prevention studiesJeffrey E Green, Tamaro Hudson
Cancer Immunology, Immunotherapy : CII|November 16, 2011
MicroRNA regulation in cancer-associated fibroblastsOlga Aprelikova, Jeffrey E Green
The Journal of Nutrition|July 4, 2003
The use of genetically altered mice for breast cancer prevention studiesClaudine Kavanaugh, Jeffrey E Green
Nucleic Acids Research|July 31, 2003
Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactionsStanislaw J Kaczmarczyk, Jeffrey E Green
Pharmacogenomics|February 19, 2014
Predictive biomarker candidates for the response of gastric cancer to targeted and cytotoxic agentsHark Kyun Kim, Jeffrey E Green
Breast Cancer Research : BCR|October 3, 2008
Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical modelsChristina N Bennett, Jeffrey E Green
Toxicologic Pathology|January 19, 2010
Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancerChristina N Bennett, Jeffrey E Green
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthDalit Barkan, Jeffrey E Green, Ann F Chambers
Anticancer Research|June 9, 2016
Birinapant (TL32711) Improves Responses to GEM/AZD7762 Combination Therapy in Triple-negative Breast Cancer Cell LinesDong-Joon Min, Siping He, Jeffrey E Green
Pageof 9